Inspire Medical Systems (NYSE:INSP - Get Free Report) had its price objective lowered by equities research analysts at Truist Financial from $250.00 to $235.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Truist Financial's price objective would indicate a potential upside of 27.21% from the stock's previous close.
INSP has been the topic of several other research reports. Stifel Nicolaus lowered their price objective on shares of Inspire Medical Systems from $200.00 to $190.00 and set a "hold" rating on the stock in a research report on Tuesday, January 21st. Piper Sandler lowered their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Robert W. Baird reduced their price objective on Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating for the company in a report on Tuesday. Morgan Stanley lowered their target price on Inspire Medical Systems from $230.00 to $220.00 and set an "overweight" rating on the stock in a research note on Tuesday. Finally, Wells Fargo & Company dropped their price target on Inspire Medical Systems from $198.00 to $195.00 and set an "equal weight" rating on the stock in a research report on Tuesday. Three research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $228.82.
View Our Latest Report on INSP
Inspire Medical Systems Stock Performance
Shares of Inspire Medical Systems stock traded down $2.42 during mid-day trading on Tuesday, hitting $184.73. 680,965 shares of the stock were exchanged, compared to its average volume of 564,408. The company has a market capitalization of $5.48 billion, a P/E ratio of 172.65 and a beta of 1.32. The company has a 50-day simple moving average of $189.11 and a 200 day simple moving average of $191.33. Inspire Medical Systems has a 12 month low of $123.00 and a 12 month high of $257.40.
Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings data on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. Analysts predict that Inspire Medical Systems will post 1.33 EPS for the current year.
Insider Activity at Inspire Medical Systems
In other news, CTO John Rondoni sold 583 shares of the firm's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.67. Following the sale, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. This trade represents a 5.30 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 4.10% of the stock is owned by corporate insiders.
Institutional Trading of Inspire Medical Systems
A number of hedge funds have recently bought and sold shares of the company. First Horizon Advisors Inc. raised its position in Inspire Medical Systems by 885.7% in the 4th quarter. First Horizon Advisors Inc. now owns 138 shares of the company's stock worth $26,000 after purchasing an additional 124 shares during the period. True Wealth Design LLC bought a new position in Inspire Medical Systems in the 3rd quarter worth $30,000. Farther Finance Advisors LLC lifted its holdings in Inspire Medical Systems by 1,158.3% in the third quarter. Farther Finance Advisors LLC now owns 151 shares of the company's stock worth $32,000 after buying an additional 139 shares during the period. Huntington National Bank boosted its position in Inspire Medical Systems by 228.3% during the 4th quarter. Huntington National Bank now owns 174 shares of the company's stock valued at $32,000 after acquiring an additional 121 shares in the last quarter. Finally, Harbour Investments Inc. grew its stake in Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company's stock worth $37,000 after purchasing an additional 99 shares during the period. Institutional investors own 94.91% of the company's stock.
About Inspire Medical Systems
(
Get Free Report)
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
Read More
Before you consider Inspire Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.
While Inspire Medical Systems currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
